CONMED Corp Reports Q2 2026 Financial Results

What Happened CONMED Corporation filed a Form 8-K on July 29, 2026 (Item 2.02) announcing its financial results for the second quarter ended June 30, 2026. The company issued a press release with the results, which is furnished as Exhibit 99.1 to the filing. The report was signed by John E. Gallagher, Executive Vice President, Finance & Chief Financial Officer.

Key Details

• Filing date: July 29, 2026; quarter covered: quarter ended June 30, 2026.
• Event reported under Item 2.02: Results of Operations and Financial Condition (press release attached as Exhibit 99.1).
• Press release and interactive XBRL cover page included with the 8-K for investors to review detailed figures and metrics.
• Form 8-K was signed by John E. Gallagher, CONMED EVP Finance & CFO.

Why It Matters This 8-K notifies investors that CONMED has released its quarterly earnings information—typically including revenue, net income (or loss), and other operating metrics—which can affect the stock price and investor decisions. Retail investors should read the attached press release (Exhibit 99.1) or the company’s full quarterly filings for the specific revenue, earnings per share, and any management commentary or outlook before making investment decisions. Keywords: earnings, revenue, quarterly results, CFO.